MedTrace Logo

Clinical Outcome of Autonomous Cortisol Secretion in Adrenal Incidentalomas

NCT04917757 · Status: ACTIVE_NOT_RECRUITING · Type: OBSERVATIONAL · Enrollment: 3656

Last updated 2025-09-05

Study results available
· View outcomes & findings →

Summary

The primary aim of the study is to assess mortality and cardiovascular events potentially linked to cortisol excess in patients with adrenal incidentalomas stratified by cortisol values following the 1-mg overnight dexamethasone test.

Conditions

  • Adrenal Incidentaloma

Interventions

DIAGNOSTIC_TEST

1mg Dexamethasone test

For each patient a 1mg dexamethasone test has been performed.

Sponsors & Collaborators

  • European Network for the Study of Adrenal Tumors

    collaborator OTHER_GOV

  • Wuerzburg University Hospital

    lead OTHER

Principal Investigators

  • Martin Fassnacht, MD · Wuerzburg University Hospital

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-01-01
Primary Completion
2019-08-31
Completion
2025-12-31

Countries

  • Germany
  • Italy

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04917757 on ClinicalTrials.gov